Form 8-K - Current report:
SEC Accession No. 0001104659-16-117788
Filing Date
2016-05-05
Accepted
2016-05-04 18:08:35
Documents
3
Period of Report
2016-05-03
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a16-10609_18k.htm 8-K 21227
2 EX-99.1 a16-10609_1ex99d1.htm EX-99.1 13611
3 GRAPHIC g106091mmi001.gif GRAPHIC 3099
  Complete submission text file 0001104659-16-117788.txt   40313
Mailing Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004
Business Address 25 BROADWAY, 9TH FLOOR NEW YORK NY 10004 212-203-5072
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37635 | Film No.: 161620924
SIC: 2834 Pharmaceutical Preparations